Ari Ne’eman joins Ethics Talk to discuss his article, When Disability is Defined by Behavior, Outcome Measures Should Not promote “Passing”.

Proliferation of innovative procedures and treatments in surgery has led to novel and distinct ethical challenges. Medicine can learn from plastic surgeons’ approaches to informed consent and potentially harmful treatments.

Physicians should provide women considering abortion after Down syndrome screening with unbiased information and not attempt to influence their decision.

The authors of a recent journal article believe that most doctors and clinical trial sponsors would not object to changes in regulations requiring doctors to disclose financial incentives to their patients.

The government is justified in using eminent domain to purchase patents in order to produce large amounts of medication during a public health crisis.

Physicians are cautioned that the two obstacles to reforming post-marketing clinical trials are the FDA's reluctance to revisit past approvals and its inability to enforce pharmaceutical companies' commitment to conduct Phase IV trials.

Legal and ethical questions arise when a physician receives remuneration for prescribing a drug to a patient.

The harms of communicating autism risk can be avoided by helping families to understand risk and to distinguish between poor and good sources of scientific information, which should take families’ interests into account.

Evaluation of an autism curriculum for pediatric residents yielded significant short-term gains in residents’ objective and self-assessed knowledge of autism spectrum disorder diagnosis and treatment.